Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-Current Debt (2023 - 2025)

AVITA Medical (RCEL) has disclosed Non-Current Debt for 3 consecutive years, with $42.2 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non-Current Debt rose 2.99% year-over-year to $42.2 million, compared with a TTM value of $42.2 million through Jun 2025, up 2.99%, and an annual FY2024 reading of $42.2 million, up 6.11% over the prior year.
  • Non-Current Debt was $42.2 million for Q2 2025 at AVITA Medical, up from $41.5 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $42.5 million in Q3 2024 and bottomed at $39.8 million in Q4 2023.
  • Average Non-Current Debt over 3 years is $41.5 million, with a median of $41.5 million recorded in 2025.
  • The sharpest move saw Non-Current Debt increased 6.11% in 2024, then increased 0.39% in 2025.
  • Year by year, Non-Current Debt stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then fell by 0.07% to $42.2 million in 2025.
  • Business Quant data shows Non-Current Debt for RCEL at $42.2 million in Q2 2025, $41.5 million in Q1 2025, and $42.2 million in Q4 2024.